Novel autologous T-cell therapy for drug-resistant cytomegalovirus disease after lung transplantation.

predictive of cardiovascular death and heart failure hospitalization in heart failure patients. J Am Coll Cardiol 2015;65:657-65. 4. Bayes-Genis A, Barallat J, Pascual-Figal D, et al. Prognostic value and kinetics of soluble neprilysin in acute heart failure. A pilot study. JACC Heart Fail 2015;3:341-4. 5. Yandle TG, Richards M, Smith M, et al. Assay of endopeptidase-24 11 activity in plasma applied to in vivo studies of endopeptidase inhibitors. Clin Chem 1992;38:1785-91. 6. Vodovar N, Seronde MF, Laribi S, et al. Elevated plasma B-type natriuretic peptide concentrations directly inhibit circulating neprilysin activity in heart failure. JACC Heart Fail 2015;3:629-36.